Docusign (NASDAQ:DOCU) Director Teresa Briggs Sells 364 Shares

Key Points

  • Insider sale: Director Teresa Briggs sold 364 shares on Feb. 27 at an average price of $44.31 (~$16,129), trimming her position by 3.82% to 9,170 shares still valued around $406,323.
  • Analysts have been lowering targets—Jefferies cut DOCU to a Hold with a $45 target and several other firms trimmed theirs—leaving a MarketBeat consensus rating of "Hold" with an average price target of $78.80.
  • Shares traded down about 1.4% to $45.07 on very heavy volume, sitting near the 1‑year low ($40.16) and well below the 50‑ and 200‑day moving averages ($56.08 and $66.63), with a market cap of roughly $9.03 billion.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) Director Teresa Briggs sold 364 shares of the stock in a transaction on Friday, February 27th. The stock was sold at an average price of $44.31, for a total value of $16,128.84. Following the transaction, the director directly owned 9,170 shares in the company, valued at $406,322.70. The trade was a 3.82% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Docusign Stock Down 1.4%

NASDAQ:DOCU traded down $0.65 during mid-day trading on Friday, reaching $45.07. The company's stock had a trading volume of 18,041,867 shares, compared to its average volume of 5,176,565. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $94.67. The stock has a fifty day moving average of $56.08 and a 200-day moving average of $66.63. The firm has a market capitalization of $9.03 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.99 and a beta of 1.00.

Analysts Set New Price Targets




DOCU has been the subject of a number of analyst reports. Jefferies Financial Group lowered Docusign from a "buy" rating to a "hold" rating and lowered their target price for the stock from $105.00 to $45.00 in a report on Monday. HSBC set a $53.00 target price on Docusign in a research note on Friday, February 13th. BTIG Research lowered their price target on shares of Docusign from $88.00 to $70.00 and set a "buy" rating on the stock in a report on Wednesday, February 18th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Docusign in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada decreased their target price on shares of Docusign from $95.00 to $70.00 and set a "sector perform" rating for the company in a research report on Monday, January 5th. Five investment analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. According to data from MarketBeat.com, Docusign currently has an average rating of "Hold" and an average price target of $78.80.

Check Out Our Latest Stock Analysis on DOCU

Docusign News Roundup

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Nvidia CEO comments eased fears that AI will cannibalize enterprise software, sparking a session where DocuSign and other software names traded up — a sentiment boost that can help stabilize shares if sustained. DocuSign, MongoDB, Workiva, Elastic, and PagerDuty Stocks Trade Up, What You Need To Know
  • Neutral Sentiment: AAII published a comparative piece weighing DocuSign vs. EverCommerce, useful for investors doing relative-value or thematic SaaS allocations but not a near-term catalyst. Which Is a Better Investment, DocuSign, Inc. or EverCommerce Inc. Stock?
  • Neutral Sentiment: Reported short-interest figures for February appear to contain errors (showing 0 shares/NaN changes) and therefore offer no clear signal about bearish positioning — treat that data as unreliable until restated. (Data source summary)
  • Negative Sentiment: A MarketBeat piece framing the software sell-off singled out DocuSign as exposed to AI-driven commoditization and product concentration risks, arguing the company lacks the durable moats that protect other AI beneficiaries — this narrative pressures valuations and investor confidence. AI Is Separating Software Winners From Losers, 2 Experts Explain (DOCU)
  • Negative Sentiment: Commentary asking whether it’s time to reassess DocuSign after a prolonged share-price slump highlights sizable multi-timeframe declines and reinforces a cautious investor stance; such coverage can prolong negative momentum. Is It Time To Reassess DocuSign (DOCU) After Its Prolonged Share Price Slump
  • Negative Sentiment: A director (Teresa Briggs) executed a small sale (~364 shares, ~$16k). The size is modest, so it’s more a datapoint than a major red flag, but insider selling can be perceived negatively in a down market. SEC Filing: Insider Sale by Teresa Briggs

Hedge Funds Weigh In On Docusign

Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Docusign by 1.1% during the 3rd quarter. Vanguard Group Inc. now owns 21,625,551 shares of the company's stock worth $1,558,986,000 after acquiring an additional 225,525 shares during the period. State Street Corp raised its stake in Docusign by 0.9% during the fourth quarter. State Street Corp now owns 8,193,805 shares of the company's stock worth $560,456,000 after purchasing an additional 77,008 shares during the period. Capital World Investors boosted its holdings in Docusign by 38.1% in the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company's stock valued at $397,801,000 after purchasing an additional 1,603,900 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Docusign by 1.6% in the 2nd quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after buying an additional 86,560 shares during the period. Finally, Geode Capital Management LLC increased its holdings in shares of Docusign by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 4,084,463 shares of the company's stock worth $278,665,000 after buying an additional 18,873 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company's flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign's Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign's platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

See Also

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Docusign?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Docusign and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles